NYU Grossman School of Medicine launches Journal Club series with expert insights on ophthalmology research

(Image credit: Adobe Stock/Postmodern Studio)

The NYU Grossman School of Medicine Department of Ophthalmology and Ophthalmology Times will host visiting faculty members from all ophthalmologic disciplines and a variety of academic departments in an innovative Journal Club series.

Faculty members and our residents will highlight salient findings in recent impactful papers and interpret the methodology, results, and potential impact on clinical practice. This mentored approach to literature review will equip trainees to critically evaluate emerging data and techniques that guide patient care.

We aim for an understanding of literature beyond the published conclusions that probes study design, methodology, and supplementary data to consider “How and Why?” studies are conducted and presented as they are. Medicine and ophthalmology, in particular, continue to advance at an exciting pace.

It is essential to avoid passive information overload and instead assimilate this expanding knowledge analytically. We hope that this series will allow clinicians at various levels of training to stay abreast of new developments in the field and ultimately provide the highest level of care to their patients.

For our first installment, we are fortunate enough to sit down with Deepinder Dhaliwal, MD, Lac, a cornea and refractive surgeon at the University of Pittsburgh, to discuss the latest research in surgical management of Fuchs endothelial corneal dystrophy and one of her recent papers on long-term outcomes in Descemet stripping only.

Kathryn A. Colby, MD, PhD

Colby is the Elisabeth J. Cohen, MD, Professor of Ophthalmology and chair of the Department of Ophthalmology at the NYU Grossman School of Medicine in New York, New York. She is an internationally renowned academic corneal specialist with a longstanding interest in Fuchs dystrophy, the most common reason for corneal transplantation in the US. She is pioneering novel, nontransplant treatments for this condition. She has expertise in managing ocular surface tumors, pediatric corneal disease, infectious keratitis and keratoprosthesis.